HCPCS Level IIdrugActive
J9179
Eribulin mesylate injection
BETOS: O1D
Effective: 2012-01-01
Description
Injection, eribulin mesylate, 0.1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Eribulin Mesylate
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
0.1 MG
Billing Units
10.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.